Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052624
Status:
UNKNOWN
Last Update Posted:
2018-05-15
First Post:
2003-01-24
Brief Title:
Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma
Sponsor:
Xenova Biomedix
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
MUSC-10550
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xenova Biomedix
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None